المؤلفون: Martin Zeitz, C Hayford, M Häder, BM Wittig

المصدر: Zeitschrift für Gastroenterologie. 41

مصطلحات موضوعية: Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a92526e944df8b53c6841f2487d5cc16
https://doi.org/10.1055/s-0035-1555160

المؤلفون: U. Hoffmann, Christian Barmeyer, Martin Zeitz, U. Günthert, Joerg-Dieter Schulzke, C. Loddenkemper, BM Wittig

المصدر: Zeitschrift für Gastroenterologie. 44

مصطلحات موضوعية: Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e615b02f8098c3361793c93abb757149
https://doi.org/10.1055/s-2006-950616

المؤلفون: BM Wittig, U. Hoffmann, Martin Zeitz, U. Guenthert, C Hayford

المصدر: Zeitschrift für Gastroenterologie. 43

مصطلحات موضوعية: Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::20de2d7e3f1a7fa24aed090d891da2d5
https://doi.org/10.1055/s-2005-919851

المؤلفون: U. Guenthert, BM Wittig, C Hayford, K Stauffer, Martin Zeitz

المصدر: Zeitschrift für Gastroenterologie. 42

مصطلحات موضوعية: Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::891a8402e8786dda3bb9ca295c3722b2
https://doi.org/10.1055/s-2004-831535

المؤلفون: Preuss I, Haas S, Eichhorn U, Eberhagen I, Kaufmann M, Beck T, Rh, Eibl, Dall P, Bauknecht T, Jan Hengstler, Bm, Wittig, Dippold W, Kaina B

المصدر: Web of Science
Scopus-Elsevier
Europe PubMed Central

مصطلحات موضوعية: Male, Ovarian Neoplasms, Brain Neoplasms, Colon, Breast Neoplasms, Methyltransferases, In Vitro Techniques, O(6)-Methylguanine-DNA Methyltransferase, Testicular Neoplasms, Reference Values, Neoplasms, Humans, Female, Breast, Colorectal Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::323fe658b98d5a8e7542849c11392dc3
https://pubmed.ncbi.nlm.nih.gov/8706038

المؤلفون: Martin Feuchtenberger, Kleinert S, Ec, Scharbatke, Gnann H, Behrens F, Bm, Wittig, Greger G, Hp, Tony

المصدر: Europe PubMed Central

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e7014d5544505cd65d4261c83d4eefa
http://europepmc.org/abstract/med/25897681

المؤلفون: Behrens F; Division of Rheumatology, University Hospital Frankfurt, Goethe University , Frankfurt am Main , Germany.; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP , Frankfurt am Main , Germany., Koehm M; Division of Rheumatology, University Hospital Frankfurt, Goethe University , Frankfurt am Main , Germany.; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP , Frankfurt am Main , Germany., Schwaneck EC; Medizinische Klinik und Poliklinik 2, Department of Rheumatology and Clinical Immunology, University Hospital Würzburg , Würzburg , Germany., Schmalzing M; Medizinische Klinik und Poliklinik 2, Department of Rheumatology and Clinical Immunology, University Hospital Würzburg , Würzburg , Germany., Wittig BM; AbbVie Germany GmbH & Co. KG , Wiesbaden , Germany., Gnann H; Department of Biostatistics, GKM , Munich , Germany., Greger G; AbbVie Germany GmbH & Co. KG , Wiesbaden , Germany., Tony HP; Medizinische Klinik und Poliklinik 2, Department of Rheumatology and Clinical Immunology, University Hospital Würzburg , Würzburg , Germany., Burkhardt H; Division of Rheumatology, University Hospital Frankfurt, Goethe University , Frankfurt am Main , Germany.; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP , Frankfurt am Main , Germany.

المصدر: Scandinavian journal of rheumatology [Scand J Rheumatol] 2019 Sep; Vol. 48 (5), pp. 375-382. Date of Electronic Publication: 2019 Jul 16.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1502-7732 (Electronic) Linking ISSN: 03009742 NLM ISO Abbreviation: Scand J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*therapeutic use , Arthritis, Psoriatic/*drug therapy , Arthritis, Rheumatoid/*drug therapy , Methotrexate/*therapeutic use, Antirheumatic Agents/therapeutic use ; Disease Progression ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome

المؤلفون: Wittig BM; Medical Clinic 1 (Gastroenterology/Infectiology/Rheumatology), University Medicine Charité, Berlin, Germany., Sabat R; Interdisciplinary Group of Molecular Immunopathology and Psoriasis Research and Treatment Center, Dermatology/Medical Immunology, University Medicine Charité, Berlin, Germany., Holzlöhner P; Medical Clinic 1 (Gastroenterology/Infectiology/Rheumatology), University Medicine Charité, Berlin, Germany., Witte-Händel E; Interdisciplinary Group of Molecular Immunopathology and Psoriasis Research and Treatment Center, Dermatology/Medical Immunology, University Medicine Charité, Berlin, Germany., Heilmann K; Medical Clinic 1 (Gastroenterology/Infectiology/Rheumatology), University Medicine Charité, Berlin, Germany., Witte K; Interdisciplinary Group of Molecular Immunopathology and Psoriasis Research and Treatment Center, Dermatology/Medical Immunology, University Medicine Charité, Berlin, Germany., Triebus J; Interdisciplinary Group of Molecular Immunopathology and Psoriasis Research and Treatment Center, Dermatology/Medical Immunology, University Medicine Charité, Berlin, Germany., Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Laman JD; Department of Neuroscience, University Medical Center Groningen, Groningen, The Netherlands., Bokemeyer B; Gastroenterology Practice, Minden, Germany., Terracciano L; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Schwärzler C; Federal Polytechnic University Lausanne (Flow Cytometry Core Facility), Lausanne, Switzerland., Kohler H; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Volkmer R; Institute for Medical Immunology, University Medicine Charité, Berlin, Germany., Loddenkemper C; Institute of Pathology, University Medicine Charité, Berlin, Germany., Wolk K; Interdisciplinary Group of Molecular Immunopathology and Psoriasis Research and Treatment Center, Dermatology/Medical Immunology, University Medicine Charité, Berlin, Germany., Hoffmann U; Medical Clinic 1 (Gastroenterology/Infectiology/Rheumatology), University Medicine Charité, Berlin, Germany., Günthert U; Institute of Pathology, University Hospital Basel, Basel, Switzerland.

المصدر: Mucosal immunology [Mucosal Immunol] 2018 May; Vol. 11 (3), pp. 846-860. Date of Electronic Publication: 2017 Nov 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101299742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3456 (Electronic) Linking ISSN: 19330219 NLM ISO Abbreviation: Mucosal Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Colitis/*immunology , Crohn Disease/*immunology , Hyaluronan Receptors/*metabolism , Macrophages/*physiology , T-Lymphocyte Subsets/*physiology , T-Lymphocytes, Regulatory/*physiology, Adult ; Alternative Splicing ; Animals ; Cells, Cultured ; Coculture Techniques ; Cytokines/metabolism ; Disease Models, Animal ; Exons/genetics ; Female ; Forkhead Transcription Factors/metabolism ; Humans ; Hyaluronan Receptors/genetics ; Inflammation Mediators/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Knockout ; Mice, Transgenic ; Osteopontin/metabolism

المؤلفون: Kucharzik T; Department of Internal Medicine and Gastroenterology, University Teaching Hospital Lüneburg, Lüneburg, Germany. Electronic address: torsten.kucharzik@klinikum-lueneburg.de., Wittig BM; Medical Department, AbbVie Deutschland GmbH & Co, KG, Wiesbaden, Germany., Helwig U; Gastroenterology Practice, Oldenburg, Germany., Börner N; Gastroenterology Practice, Mainz, Germany., Rössler A; Medical Department, AbbVie Deutschland GmbH & Co, KG, Wiesbaden, Germany., Rath S; Medical Department, AbbVie Deutschland GmbH & Co, KG, Wiesbaden, Germany., Maaser C; Ambulanzzentrum Gastroenterologie, University Teaching Hospital Lüneburg, Lüneburg, Germany.

مؤلفون مشاركون: TRUST study group

المصدر: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2017 Apr; Vol. 15 (4), pp. 535-542.e2. Date of Electronic Publication: 2016 Nov 14.

نوع المنشور: Evaluation Study; Journal Article

بيانات الدورية: Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-7714 (Electronic) Linking ISSN: 15423565 NLM ISO Abbreviation: Clin Gastroenterol Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease/*diagnostic imaging , Crohn Disease/*pathology , Drug Monitoring/*methods , Immunologic Factors/*therapeutic use , Intestines/*diagnostic imaging , Intestines/*pathology , Ultrasonography/*methods, Adolescent ; Adult ; Aged ; Crohn Disease/drug therapy ; Female ; Germany ; Humans ; Male ; Middle Aged ; Prospective Studies ; Young Adult

المؤلفون: Behrens F; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Koehm M; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Arndt U; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Wittig BM; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Greger G; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Thaçi D; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Scharbatke E; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Tony HP; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg., Burkhardt H; From the Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt am Main; Rheumapraxis Hofheim, Hofheim; AbbVie Deutschland GmbH and Co. KG, Wiesbaden; Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus, Luebeck; and Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg, Würzburg, Germany.F. Behrens, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; M. Koehm, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; H. Burkhardt, MD, Division of Rheumatology, University Hospital Frankfurt, Goethe University, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP; U. Arndt, MD, Rheumapraxis Hofheim; B.M. Wittig, MD, AbbVie Deutschland GmbH and Co. KG; G. Greger, PhD, AbbVie Deutschland GmbH and Co. KG; D. Thaçi, MD, Comprehensive Center of Inflammation Medicine, University Hospital Schleswig-Holstein Campus; E. Scharbatke, MD; H.P. Tony, MD, Schwerpunkt Rheumatologie/Klinische Immunologie Medizinische Klinik und Poliklinik II, Universität Würzburg. Harald.Burkhardt@kgu.de.

المصدر: The Journal of rheumatology [J Rheumatol] 2016 Mar; Vol. 43 (3), pp. 632-9. Date of Electronic Publication: 2015 Dec 15.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Adalimumab/*therapeutic use , Antirheumatic Agents/*therapeutic use , Arthritis, Psoriatic/*drug therapy , Methotrexate/*therapeutic use, Adult ; Disease Progression ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome